AstraZeneca (AZN) Financial Ratios: P/E, ROE & More

AstraZeneca (AZN) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), AstraZeneca had a P/E ratio of 28.15 (down from 28.88), return on equity of 22.8% (up from 17.6%), debt-to-equity of 0.61 (down from 0.74) and a current ratio of 0.94 (up from 0.93). A current ratio of 0.94 means current liabilities exceed current assets. Its dividend yield was 1.72% with a payout ratio of 47.4%.

AstraZeneca Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income Statement Balance Sheet Cash Flow Ratios

Scroll to see more

Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Valuation Ratios
P/E Ratio	28.15	28.88	35.14	63.70	1625.31	41.07
P/S Ratio	4.90	3.76	4.57	4.72	4.87	4.93
P/B Ratio	5.91	4.97	5.34	5.65	4.63	8.39
Price/FCF	24.46	20.45	23.29	24.03	37.36	34.20
Price/OCF	19.75	17.13	20.23	21.35	30.53	27.35
Enterprise Value Ratios
EV/Revenue	5.32	4.22	5.13	5.38	5.60	5.63
EV/EBITDA	16.20	12.99	16.45	17.34	31.27	21.44
EV/EBIT	21.86	17.65	24.21	27.05	72.32	34.29
EV/FCF	26.55	22.96	26.14	27.35	43.01	39.04
Profitability & Returns
Return on Equity (ROE)	22.84%	17.59%	15.64%	8.63%	0.42%	20.80%
Return on Assets (ROA)	8.19%	7.88%	6.14%	5.46%	2.10%	4.26%
Return on Invested Capital (ROIC)	17.03%	16.27%	13.42%	13.75%	6.00%	11.87%
Return on Capital Employed (ROCE)	17.10%	17.00%	13.70%	12.60%	3.50%	9.40%
Leverage & Solvency Ratios
Debt/Equity	0.61	0.74	0.76	0.84	0.85	1.45
Debt/EBITDA	1.51	1.70	2.04	2.23	4.81	3.15
Debt/FCF	2.52	3.06	3.30	3.57	6.85	5.92
Liquidity Ratios
Current Ratio	0.94	0.93	0.82	0.86	1.16	0.96
Quick Ratio	0.65	0.67	0.58	0.61	0.67	0.67
Efficiency Ratios
Asset Turnover	0.54	0.53	0.46	0.44	0.43	0.42
Inventory Turnover	1.81	1.80	1.59	1.26	1.85	1.45
Yield & Distribution Ratios
Earnings Yield	3.55%	3.46%	2.85%	1.57%	0.06%	2.44%
FCF Yield	4.09%	4.89%	4.29%	4.16%	2.68%	2.92%
Dividend Yield	1.72%	2.37%	2.15%	2.15%	2.44%	2.85%
Payout Ratio	47.39%	65.47%	75.42%	132.73%	3442.86%	111.77%
Buyback Yield	0.06%	-0.06%	-0.13%	-9.32%	-8.68%	-0.92%
Total Return	1.79%	2.30%	2.02%	-7.17%	-6.24%	1.93%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About AstraZeneca Financial Ratios

What is AstraZeneca's P/E ratio?

AstraZeneca's P/E ratio was 28.15 for fiscal 2025 (period ended Dec 31, 2025). It was 28.88 a year earlier.

What is AstraZeneca's return on equity?

AstraZeneca's return on equity (ROE) was 22.8% for fiscal 2025 (period ended Dec 31, 2025). It was 17.6% a year earlier.

What is AstraZeneca's debt-to-equity ratio?

AstraZeneca's debt-to-equity ratio was 0.61 for fiscal 2025 (period ended Dec 31, 2025). It was 0.74 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition